ChloroquineV1, Main, Exploration, bibRecord, 003300

Fansidar hypersensitivity pneumonitis

Identifieur interne : 003300 ( Main/Exploration ); précédent : 003299; suivant : 003301

Fansidar hypersensitivity pneumonitis

Auteurs : David Mccormack [Canada] ; W. K. C. Morgan [Canada]

Source :

British Journal of Diseases of the Chest [ 0007-0971 ] ; 1987.

RBID : ISTEX:B781C87497E2DECDF18062E1033318ADFE0851C4

English descriptors

Teeft :
- Acute illness, Adverse effects, Adverse reactions, Allergic reaction, Allergy, Alveolar walls, Alveolitis, Arthralgia, August, Blood dyscrasias, Blood pressure, Canada london, Case report, Cellular infiltration, Chest radiograph, Christensen, Clinical microbiologist, Csokonay, Dermatological, Dermatological problems, Desquamation, Discussion fansidar, Drug allergies, Drug fever, Dyscrasia, Early collagen formation, Endemic, Enquiry, Eosinophil, Extubated, Fair number, Falciparum, Fansidar, Fansidar hypersensitivity, Fansidar hypersensitivity pneumonitis david mccormack department, Fevjfvc, Fevjfvc pred, Fibroblastic, Fibroblastic reaction, Government printing office, Husp, Husp pharm, Hypersensitivity, Hypersensitivity pneumonitis, Illness onset, Inspiratory, Insulindependent, Insulindependent diabetes mellitus, Intensive care unit, Introduction fansidar, Kenya, Lancet, Leucocyte, Lifethreatening, Lifethreatening complication, Litre, Lung tissue, Macrophage, Malaria, Malaria prophylaxis, Malarial, Malarial prophylaxis, Mast cells, Mccormack, Mechanical ventilation, Mellitus, Microbiologist, Minimal exertion, Mononuclear cells, Morbidity, Morgan university, Mortality world reports, Myalgia, Numerous macrophages, Oedematous, Ontario, Open lung biopsy, Other hand, Other medication, Other regions, Other sulphonamides, Outpatient clinic, Patient pred, Pharm, Physical examination, Pneumonitis, Polymorphar, Polymorphar leucocytes, Pred, Prophylaxis, Pulmonary function tests, Pulmonary toxicity, Pyrimethamine, Radiograph, Regular exercise, Reprint, Respiratory failure, Respiratory rate, Serious reactions, Severe hypersensitivity pneumonia, Side effects, Social services, Specific enquiries, Steady recovery, Steroid, Subacute, Subacute alveolitis, Such areas, Sulpha, Sulpha drugs, Sulphadoxine, Sulphadoxine component, Sulphonamides, Sweats, Switzerland canada patient, Tentative diagnosis, Thoracotomy, Thoracotomy scar, Toxicity, Uneventful, University hospital, University professor, Western ontario.

Abstract

Abstract: We report a subject who had Fansidar prescribed to him for the purpose of malaria prophylaxis. This agent is a combination of pyrimethamine and sulphadoxine. He subsequently developed severe hypersensitivity pneumonia and required mechanical ventilation. We believe that sulphadoxine was responsible for his illness.

Url:

https://api.istex.fr/ark:/67375/6H6-XZJQ20NG-3/fulltext.pdf

DOI: 10.1016/0007-0971(87)90140-9

Affiliations:

Canada

Links toward previous steps (curation, corpus...)

to stream Istex, to step Corpus: 000F35
to stream Istex, to step Curation: 000F35
to stream Istex, to step Checkpoint: 002059
to stream Main, to step Merge: 003372
to stream Main, to step Curation: 003300

Le document en format XML

<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>Fansidar hypersensitivity pneumonitis</title>
<author><name sortKey="Mccormack, David" sort="Mccormack, David" uniqKey="Mccormack D" first="David" last="Mccormack">David Mccormack</name>
</author>
<author><name sortKey="Morgan, W K C" sort="Morgan, W K C" uniqKey="Morgan W" first="W. K. C." last="Morgan">W. K. C. Morgan</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:B781C87497E2DECDF18062E1033318ADFE0851C4</idno>
<date when="1987" year="1987">1987</date>
<idno type="doi">10.1016/0007-0971(87)90140-9</idno>
<idno type="url">https://api.istex.fr/ark:/67375/6H6-XZJQ20NG-3/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000F35</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000F35</idno>
<idno type="wicri:Area/Istex/Curation">000F35</idno>
<idno type="wicri:Area/Istex/Checkpoint">002059</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">002059</idno>
<idno type="wicri:doubleKey">0007-0971:1987:Mccormack D:fansidar:hypersensitivity:pneumonitis</idno>
<idno type="wicri:Area/Main/Merge">003372</idno>
<idno type="wicri:Area/Main/Curation">003300</idno>
<idno type="wicri:Area/Main/Exploration">003300</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a">Fansidar hypersensitivity pneumonitis</title>
<author><name sortKey="Mccormack, David" sort="Mccormack, David" uniqKey="Mccormack D" first="David" last="Mccormack">David Mccormack</name>
<affiliation wicri:level="1"><country xml:lang="fr">Canada</country>
<wicri:regionArea>Department of Medicine, University of Western Ontario, London Ontario</wicri:regionArea>
<wicri:noRegion>London Ontario</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Morgan, W K C" sort="Morgan, W K C" uniqKey="Morgan W" first="W. K. C." last="Morgan">W. K. C. Morgan</name>
<affiliation wicri:level="1"><country xml:lang="fr">Canada</country>
<wicri:regionArea>Department of Medicine, University of Western Ontario, London Ontario</wicri:regionArea>
<wicri:noRegion>London Ontario</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">British Journal of Diseases of the Chest</title>
<title level="j" type="abbrev">BJDC</title>
<idno type="ISSN">0007-0971</idno>
<imprint><publisher>ELSEVIER</publisher>
<date type="published" when="1987">1987</date>
<biblScope unit="volume">81</biblScope>
<biblScope unit="supplement">C</biblScope>
<biblScope unit="page" from="194">194</biblScope>
<biblScope unit="page" to="196">196</biblScope>
</imprint>
<idno type="ISSN">0007-0971</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0007-0971</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="Teeft" xml:lang="en"><term>Acute illness</term>
<term>Adverse effects</term>
<term>Adverse reactions</term>
<term>Allergic reaction</term>
<term>Allergy</term>
<term>Alveolar walls</term>
<term>Alveolitis</term>
<term>Arthralgia</term>
<term>August</term>
<term>Blood dyscrasias</term>
<term>Blood pressure</term>
<term>Canada london</term>
<term>Case report</term>
<term>Cellular infiltration</term>
<term>Chest radiograph</term>
<term>Christensen</term>
<term>Clinical microbiologist</term>
<term>Csokonay</term>
<term>Dermatological</term>
<term>Dermatological problems</term>
<term>Desquamation</term>
<term>Discussion fansidar</term>
<term>Drug allergies</term>
<term>Drug fever</term>
<term>Dyscrasia</term>
<term>Early collagen formation</term>
<term>Endemic</term>
<term>Enquiry</term>
<term>Eosinophil</term>
<term>Extubated</term>
<term>Fair number</term>
<term>Falciparum</term>
<term>Fansidar</term>
<term>Fansidar hypersensitivity</term>
<term>Fansidar hypersensitivity pneumonitis david mccormack department</term>
<term>Fevjfvc</term>
<term>Fevjfvc pred</term>
<term>Fibroblastic</term>
<term>Fibroblastic reaction</term>
<term>Government printing office</term>
<term>Husp</term>
<term>Husp pharm</term>
<term>Hypersensitivity</term>
<term>Hypersensitivity pneumonitis</term>
<term>Illness onset</term>
<term>Inspiratory</term>
<term>Insulindependent</term>
<term>Insulindependent diabetes mellitus</term>
<term>Intensive care unit</term>
<term>Introduction fansidar</term>
<term>Kenya</term>
<term>Lancet</term>
<term>Leucocyte</term>
<term>Lifethreatening</term>
<term>Lifethreatening complication</term>
<term>Litre</term>
<term>Lung tissue</term>
<term>Macrophage</term>
<term>Malaria</term>
<term>Malaria prophylaxis</term>
<term>Malarial</term>
<term>Malarial prophylaxis</term>
<term>Mast cells</term>
<term>Mccormack</term>
<term>Mechanical ventilation</term>
<term>Mellitus</term>
<term>Microbiologist</term>
<term>Minimal exertion</term>
<term>Mononuclear cells</term>
<term>Morbidity</term>
<term>Morgan university</term>
<term>Mortality world reports</term>
<term>Myalgia</term>
<term>Numerous macrophages</term>
<term>Oedematous</term>
<term>Ontario</term>
<term>Open lung biopsy</term>
<term>Other hand</term>
<term>Other medication</term>
<term>Other regions</term>
<term>Other sulphonamides</term>
<term>Outpatient clinic</term>
<term>Patient pred</term>
<term>Pharm</term>
<term>Physical examination</term>
<term>Pneumonitis</term>
<term>Polymorphar</term>
<term>Polymorphar leucocytes</term>
<term>Pred</term>
<term>Prophylaxis</term>
<term>Pulmonary function tests</term>
<term>Pulmonary toxicity</term>
<term>Pyrimethamine</term>
<term>Radiograph</term>
<term>Regular exercise</term>
<term>Reprint</term>
<term>Respiratory failure</term>
<term>Respiratory rate</term>
<term>Serious reactions</term>
<term>Severe hypersensitivity pneumonia</term>
<term>Side effects</term>
<term>Social services</term>
<term>Specific enquiries</term>
<term>Steady recovery</term>
<term>Steroid</term>
<term>Subacute</term>
<term>Subacute alveolitis</term>
<term>Such areas</term>
<term>Sulpha</term>
<term>Sulpha drugs</term>
<term>Sulphadoxine</term>
<term>Sulphadoxine component</term>
<term>Sulphonamides</term>
<term>Sweats</term>
<term>Switzerland canada patient</term>
<term>Tentative diagnosis</term>
<term>Thoracotomy</term>
<term>Thoracotomy scar</term>
<term>Toxicity</term>
<term>Uneventful</term>
<term>University hospital</term>
<term>University professor</term>
<term>Western ontario</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Abstract: We report a subject who had Fansidar prescribed to him for the purpose of malaria prophylaxis. This agent is a combination of pyrimethamine and sulphadoxine. He subsequently developed severe hypersensitivity pneumonia and required mechanical ventilation. We believe that sulphadoxine was responsible for his illness.</div>
</front>
</TEI>
<affiliations><list><country><li>Canada</li>
</country>
</list>
<tree><country name="Canada"><noRegion><name sortKey="Mccormack, David" sort="Mccormack, David" uniqKey="Mccormack D" first="David" last="Mccormack">David Mccormack</name>
</noRegion>
<name sortKey="Morgan, W K C" sort="Morgan, W K C" uniqKey="Morgan W" first="W. K. C." last="Morgan">W. K. C. Morgan</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003300 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003300 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:B781C87497E2DECDF18062E1033318ADFE0851C4
   |texte=   Fansidar hypersensitivity pneumonitis
}}

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021

	Serveur d'exploration Chloroquine
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration Chloroquine

Fansidar hypersensitivity pneumonitis

Fansidar hypersensitivity pneumonitis

Source :

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri